African-Canadian Study of HIV-Infected Adults and a Vaccine for Ebola - ACHIV-Ebola

NCT03031912 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

251

Enrollment

NETWORK

Sponsor class

Conditions

Ebola

Interventions

BIOLOGICAL: V920 (rVSVΔG-ZEBOV-GP) Ebola Virus Vaccine
OTHER: Saline

Sponsor

Canadian Immunization Research Network

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]